‘Highly concerning’: Hydrocortisone manufacturers' £100m fine overturned

Manufacturers that hiked hydrocortisone prices by 10,000% and paid off competitors will not have to pay “nearly £100m of fines” after a successful appeal, the Competition Appeal Tribunal (CAT) has ruled. 

CMA: “We will be appealing and remain determined to see this case through"
Kate Bowie

Read more by Kate Bowie

Kate Bowie joined C+D as a digital reporter in August 2023 after graduating from a master’s in journalism at City, University of London. She began covering the primary care beat at the end of 2022, when she carried out several health investigations focused on staffing issues, NHS funding and health inequalities.

Latest from News

More from Clinical